Maraganore John
- SEC CIK
- 0001180432
No open-market purchases or sales filed in the past year.
Current role at each company
- TAK Takeda Pharmaceutical Co LtdDirectoras of Jul 6, 2026
- KYMR Kymera Therapeutics, Inc.Directoras of Jun 25, 2026
- RAPP Rapport Therapeutics, Inc.Directoras of Jun 10, 2026
- BEAM Beam Therapeutics Inc.Directoras of Jun 5, 2026
- COAG Hemab Therapeutics Holdings, Inc.Directoras of May 4, 2026
Show 3 more companies
- PROK Prokidney Corp.Directoras of Jul 3, 2023
- AGIO Agios Pharmaceuticals, Inc.Directoras of Jun 23, 2022
- ALNY Alnylam Pharmaceuticals, Inc.Chief Executive Officeras of Dec 23, 2021
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Maraganore John as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ALNY Alnylam Pharmaceuticals, Inc.
Chief Executive Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 12, 2021 (view filing) | Nov 12 | Same day | Maraganore JohnChief Executive Officer | SSale | −34.0K | $171.52 | −$5.83M | −13.7%214.8K after | 5 lots |
| Aug 16, 2021 (view filing) | Aug 13 | 3 days | Maraganore JohnChief Executive Officer | SSale | −34.0K | $199.78 | −$6.79M | −13.7%214.8K after | 5 lots |